Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Camrelizumab and Decitabine in Elderly R/R AML
NCT04353479Phase 2Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Apr 2020
- Primary completion
- Dec 2020
- Modality
- Immune Checkpoint Inhibitors
01
Overview
A Phase 2 trial of camrelizumab in acute myeloid leukemia (AML), sponsored by Shanghai Jiao Tong University School of Medicine. Status: unknown.
02
Drugs
camrelizumab
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT04353479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04353479.